Srikram et al., 2008 - Google Patents
Analyses of vaccination protocols for Leptospira interrogans serovar autumnalis in hamstersSrikram et al., 2008
View PDF- Document ID
- 9825731886649019297
- Author
- Srikram A
- Wongratanacheewin S
- Puapairoj A
- Wuthiekanun V
- Sermswan R
- Publication year
- Publication venue
- Am J Trop Med Hyg
External Links
Snippet
Leptospirosis, caused by Leptospira spp., is a zoonotic disease found worldwide. Killed whole cell leptospiral vaccines have been used as effective vaccines to elicit specific antibodies for protection. However, the involvement of cytokine responses after vaccination …
- 241000699800 Cricetinae 0 title abstract description 66
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gomes-Solecki et al. | Animal models of leptospirosis: of mice and hamsters | |
| Maurin et al. | Q fever | |
| Bethony et al. | Vaccines to combat the neglected tropical diseases | |
| Clapp et al. | Nasal vaccination stimulates CD8+ T cells for potent protection against mucosal Brucella melitensis challenge | |
| Nair et al. | The route of infection with Leptospira interrogans serovar Copenhageni affects the kinetics of bacterial dissemination and kidney colonization | |
| Barasona et al. | Safety of African swine fever vaccine candidate Lv17/WB/Rie1 in wild boar: overdose and repeated doses | |
| Greenblatt et al. | Vaccines and dementia: part I. Non-specific immune boosting with BCG: history, ligands, and receptors | |
| Marrie et al. | Coxiella | |
| US9585949B2 (en) | Use of attenuated strains of parasites for the prevention or treatment of pathologies associates with an apicomplexan | |
| Srikram et al. | Analyses of vaccination protocols for Leptospira interrogans serovar autumnalis in hamsters | |
| EP3166632B1 (en) | Modified bacteria for improved vaccines against brucellosis | |
| Gong et al. | Chloroform-methanol residue of Coxiella burnetii markedly potentiated the specific immunoprotection elicited by a recombinant protein fragment rOmpB-4 derived from outer membrane protein B of Rickettsia rickettsii in C3H/HeN mice | |
| Struck et al. | Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18 | |
| Eladl et al. | Effect of colibacillosis on the immune response to a rabbit viral haemorrhagic disease vaccine | |
| ES2357968T3 (en) | COMPOSITIONS TO UNINCHAND AN IMMUNE RESPONSE AGAINST MYCOBACTERIUM AVIUM SUBESPECIE PARATUBERCULOSIS. | |
| RU2489165C2 (en) | PHARMACEUTICAL COMPOSITION AND METHOD OF STIMULATING IMMUNE RESPONSE TO Mycobacterium avium SUBSPECIES Paratuberculosis | |
| US20080193440A1 (en) | Method For Multiple Sclerosis Treatment and Prophylaxis By Treatment of Leptospira Infection | |
| Wong et al. | Generation of IgG antibodies against Strongyloides stercoralis in mice via immunization with recombinant antigens A133 and Ss-IR | |
| Bowling | Uncovering correlates of protection of attenuated Francisella tularensis vaccines | |
| Shetty | Host-Pathogen Interactions During Leptospirosis in Male C3H/HeJ Mice | |
| Alam | Elucidating the Mechanisms of Protective Immune Responses Against Coxiella burnetii Infection | |
| Wirata et al. | Development of hyperimmune serum for diagnosis and therapy against Jembrana disease in Bali cattle | |
| ACIK et al. | Investigation of IgG antibody levels among healthcare workers vaccinated with inactivated COVID-19 vaccine using indirect ELISA | |
| Hassan | Developing an attenuated Salmonella Typhimurium vector to deliver Cathepsin B as a prophylactic and therapeutic vaccine against Schistosoma mansoni in a pre-clinical model | |
| Pan et al. | Progress in the application of Salmonella vaccines in poultry: a mini review |